Paper · 27770892
Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
Li L and 8 others. Mater Sci Eng C Mater Biol Appl, 2017. Cited by 93 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin. Papers, record 27770892. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27770892
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chitosan | Major topic |
| Drug Carriers | Major topic |
| Drug Delivery Systems | Major topic |
| Insulin | Major topic |
| Nanoparticles | Major topic |
| Administration, Oral | |
| Animals | |
| Cell Death | |
| Cell Survival | |
| Diabetes Mellitus, Experimental | |
| Drug Liberation | |
| Dynamic Light Scattering | |
| Endocytosis | |
| Flow Cytometry | |
| HT29 Cells | |
| Humans | |
| Hypoglycemic Agents | |
| Rats, Sprague-Dawley |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,965,032 | Revolutionizing Diabetes Treatment with Insulin-loaded Nanoparticles. | Mini Rev Med Chem | 2025 | https://conductscience.org/library/papers/40965032 | PubMed |
| 40,949,486 | Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40949486 | PubMed |
| 40,922,743 | Dissolving Microneedle Patch Incorporated with Insulin Nanoparticles for The Management of Type-I Diabetes Mellitus: Formulation Development and in Vivo Monitoring. | Adv Pharm Bull | 2025 | https://conductscience.org/library/papers/40922743 | PubMed |
| 39,734,205 | Nanoparticle and microparticle-based systems for enhanced oral insulin delivery: A systematic review and meta-analysis. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39734205 | PubMed |
| 38,882,129 | Muco-Adhesive and Muco-Penetrative Formulations for the Oral Delivery of Insulin. | ACS Omega | 2024 | https://conductscience.org/library/papers/38882129 | PubMed |
| 38,629,397 | Tabletized Nanomedicine: From the Current Scenario to Developing Future Medicine. | ACS Nano | 2024 | https://conductscience.org/library/papers/38629397 | PubMed |
| 38,114,803 | Exploiting Apical Sodium-Dependent Bile Acid Transporter (ASBT)-Mediated Endocytosis with Multi-Functional Deoxycholic Acid Grafted Alginate Amide Nanoparticles as an Oral Insulin Delivery System. | Pharm Res | 2024 | https://conductscience.org/library/papers/38114803 | PubMed |
| 37,937,250 | Eco-friendly synthesis of chitosan and its medical application: from chitin extraction to nanoparticle preparation. | ADMET DMPK | 2023 | https://conductscience.org/library/papers/37937250 | PubMed |
| 36,976,228 | Chitosan/Albumin Coating Factorial Optimization of Alginate/Dextran Sulfate Cores for Oral Delivery of Insulin. | Mar Drugs | 2023 | https://conductscience.org/library/papers/36976228 | PubMed |
| 36,556,443 | Application of Nanoparticles: Diagnosis, Therapeutics, and Delivery of Insulin/Anti-Diabetic Drugs to Enhance the Therapeutic Efficacy of Diabetes Mellitus. | Life (Basel) | 2022 | https://conductscience.org/library/papers/36556443 | PubMed |
1 to 10 of 30
See all 30 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27770892
GET https://conductscience.org/api/papers/v1/27770892/cited_by?page=2